Wuxi Biologics And Bayer Enter Into Acquisition Agreement

Wuxi Biologics, A Leading Global Open-Access Biologics Technology Platform Company Offering End-To-End Solutions For Biologics Discovery, Development And Manufacturing, And Bayer Jointly Announced An Acquisition Agreement That Wuxi Biologics Germany Gmbh Will Take Over The Operations Of One Of Bayer'S Final Drug Product Manufacturing Plants In Leverkusen, Germany, And Purchase The Associated Equipment, In Combination With A Long-Term Lease Contract For The Building.Based On A Manufacturing Agreement To Be Negotiated, The Plant Would Be Operated By Wuxi Biologics And Serve As A Back-Up Site For The Final Product Manufacturing Of Kovaltry&Trade;, An Antihemophilic Factor (Recombinant). The Transaction Is Expected To Be Concluded In The Coming Months Subject To The Satisfaction Of Customary Closing Conditions. Financial Details Were Not Disclosed."We Are Excited To Sign This Acquisition Agreement With Bayer, Allowing Us To Have Quick Access To High Quality Drug Product Manufacturing Capacities And Capabilities," Said Dr. Chris Chen, Ceo Of Wuxi Biologics. "Our Business In Eu, Us And China Market Has Experienced Robust Growth In The Past Few Years. This Additional Drug Product Plant Further Confirms Our Commitment To 'Global Dual Sourcing Within Wuxi Biologics' Strategy. Wuxi Biologics Will Continue To Expand Our Worldwide Capacity, Providing Global Partners With A Robust And Premier-Quality Supply Chain Network To Benefit Patients Worldwide

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!